Listed

LifeMD, Inc.

LFMDNasdaqCIK 948320HealthcareFiscal year ends Dec 31

Reports and events: 227 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

LifeMD, Inc., Reports and events
FiledFormWhat it isAccession number
2021-04-0110:40 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-007652
2021-03-3016:47 ET10-KAnnual reportPeriod 2020-12-310001493152-21-007194
2021-03-1916:15 ETSC 13DOwnership report, active investor0001493152-21-006434
2021-02-2617:00 ET8-K3.02 Unregistered sale of equity0001493152-21-004957
2021-02-2207:30 ET8-K5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-004461
2021-02-1208:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-003475
2021-02-1016:00 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-003253
2021-02-0417:00 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-21-002670
2021-02-0210:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-002352
2021-01-2817:30 ET8-K/A1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-002040
2021-01-2617:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-21-001825
2021-01-1916:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-001316
2021-01-1416:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-21-001050
2021-01-1416:15 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-001049
2021-01-1116:15 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-000746
2020-12-2916:39 ETS-1/ARegistration statement, amended0001493152-20-024458
2020-12-2817:10 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-024368
2020-12-1117:25 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-023418
2020-12-0716:29 ETDEF 14AProxy statementPeriod 2020-12-070001493152-20-023039
2020-12-0317:00 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-022915
2020-11-2517:28 ETS-1Registration statement0001493152-20-022576
2020-11-2517:05 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-022570
2020-11-2015:03 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-20-022078
2020-11-1716:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-021846
2020-11-1616:59 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-021737
2020-11-1016:22 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-020933
2020-11-0409:27 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-20-020442
2020-10-2217:30 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-019842
2020-10-1910:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-019603
2020-10-1517:15 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-20-019512
2020-09-3016:59 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-018632
2020-09-2916:07 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-20-018539
2020-08-3108:35 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-20-016971
2020-08-1916:15 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-20-016307
2020-08-1716:59 ET8-K8.01 Other events0001493152-20-016112
2020-08-1417:05 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-015934
2020-07-2817:18 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-20-014114
2020-06-1914:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-011479
2020-05-2716:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-20-009918
2020-05-1916:44 ET10-QQuarterly reportPeriod 2020-03-310001493152-20-009421
2020-05-0809:24 ET8-K8.01 Other events0001493152-20-008022
2020-03-3017:19 ET10-KAnnual reportPeriod 2019-12-310001493152-20-005288
2020-03-2617:00 ET8-K/A1.01 Entry into a material agreement; 3.03 Change to security holders’ rights0001493152-20-004814
2020-02-2817:23 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights0001493152-20-003163
2020-01-2417:27 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001213900-20-001789
2020-01-1617:00 ET8-K5.07 Shareholder vote results0001213900-20-001209
2019-12-1613:53 ETDEF 14AProxy statementPeriod 2020-01-100001213900-19-026229
2019-12-1108:42 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-19-025824
2019-11-1415:45 ET10-QQuarterly reportPeriod 2019-09-300001213900-19-023444
2019-09-1113:51 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-19-017717

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.